All.Can Canada

If you are a Canadian living with cancer, or a caregiver or family member to someone living with cancer, please visit the COVID-19 Cancer Patient Support Hub for mental health and wellness support, reliable information and resources, and practical support for meeting your everyday needs such as access to food delivery, travel support, and digital connectivity.

With the growing burden of cancer and financial pressures on our health care systems, there is an urgent need to improve the efficiency in cancer care.  Improving efficiency is not a question of linear cost-cutting – but of finding ways to allocate resources more efficiently to achieve better outcomes for patients.  This will require tough decisions, and thinking in terms of long-term investments rather than short-term policy fixes.

 

About All.Can

All.Can is an international, multi-stakeholder policy initiative aiming to identify ways we can optimize the use of resources in cancer care by focusing on outcomes that matter most to patients – and create greater efficiency in cancer care. This involves examining what system inefficiencies exist, finding examples of how we can improve efficiency in cancer care and implementing concrete policy actions based on these findings.

All.Can is comprised of leading representatives from patient organizations, policymakers, health care professionals, research and industry. The All.Can Group consists of All.Can International, plus All.Can national initiatives currently established in 14 countries including Canada.

 

About All.Can Canada

In April 2018, Save Your Skin Foundation (SYSF), a national patient-led not-for-profit group dedicated to leading the fight against non-melanoma skin cancers, melanoma and ocular melanoma, was established as All.Can Canada’s Secretariat to lead the initiative in Canada. SYSF convened a Working Group to discuss how to bring All.Can into the Canadian healthcare space. The Working Group completed a year one discovery phase that involved an informal literature review of nation-wide and province-specific health care reports to identify the top reported areas of waste and inefficiency in cancer care in Canada. These findings were then prioritized through anonymous surveys with cancer care stakeholder groups, including patient group representatives, health care professionals, provincial policy makers, health technology assessment bodies, and pharmaceutical industry representatives. This information was also reviewed in light of responses from over 300 Canadian cancer patients who took part in the All.Can International Patient Survey.

This information was used to produce a Consolidated Report of Waste and Inefficiency in Canadian Cancer Care: Multi-Stakeholder Insights and Recommendations. This report highlights the common themes across stakeholder groups of areas of greatest waste and inefficiency in Canadian cancer care systems.

All.Can Canada, through SYSF and its working group, organized a first multi-stakeholder roundtable in late 2019 to develop consensus on a focus area to begin its work. The consensus statement developed for All.Can Canada is to focus on optimizing patient entry into Canadian cancer care systems, ensuring swift, accurate and appropriately delivered diagnosis and that patients experience coordinated, effective support throughout their treatment experienceThe preliminary focus will be on ensuring swift, accurate and appropriately delivered diagnosis as the entry point into the cancer care system.

To direct All.Can Canada’s activities, a multi-stakeholder, patient-led Interim Steering Committee was established to direct an environmental scan to evaluate the capacity of the current cancer care systems in Canada to achieve the consensus statement and provide the basis of the future objectives and action plan for All.Can Canada; to organize a second, multi-stakeholder roundtable to assess the results of the environmental scan; and to determine the objectives and action plan. The final report from this research, Optimizing Entry into Canadian Cancer Care Systems: An Environmental Scan, is in the final stages of production and will be used to direct conversations at the second roundtable meeting in late 2021.

 

All.Can Canada Activities & Milestones

  • Gathered real world data and patient-reported areas of inefficiency and waste through a national patient survey with 300+ respondents and a scan of literature on nation-wide and province specific health care reports
  • Validated and prioritized data through consultation with pharmaceutical industry partners, patient representative groups, health care professionals, health technology assessment bodies and policy makers
  • Hosted an inaugural roundtable meeting of all key oncology stakeholder sectors to find consensus on the top areas of inefficiency and waste in Canadian cancer care and identify the area of focus for All.Can Canada in 2020 and beyond
  • Distributed Roundtable Report and final Consolidated report on waste and inefficiency in Canadian cancer care with consensus statement to attendees and stakeholders
  • Assembled All.Can Canada interim steering committee with representation from all stakeholder groups to support, guide and oversee the progress of a multi-year research project that was derived from the roundtable
  • Conducted a rigorous environmental scan, including literature review, patient interviews, and provider survey, to assess the current state of cancer diagnosis within Canadian cancer care systems, gather nominated practices, provide insights for a preliminary quality framework, and offer recommendations for change
  • Launched COVID-19 Cancer Patient Support Hub, bringing together Canadian oncology patient groups, mental health expertise and health care providers to respond to immediate, emotional and practical needs of Canadian oncology patients during the COVID-19 pandemic

 

All.Can Canada’s Interim Steering Committee

The All.Can Canada Steering Committee includes representation from all stakeholder groups and supports, guides and oversees the progress of this multi-year project. For more information please contact all.can@saveyourskin.ca.

 

  • Kathleen Barnard, President, Save Your Skin Foundation, BC
  • Louise Binder, Health Policy Consultant, Save Your Skin Foundation, ON
  • Alex Chambers, Manager, National Oncology Policy, Novartis Pharmaceuticals Canada, ON
  • Martine Elias, Executive Director, Myeloma Canada, QC
  • Fred Horne, Health Policy Consultant, Principal, Horne and Associates, ON
  • Rachael Manion, Executive Director, Canadian Skin Patient Alliance/Canadian Association of Psoriasis Patients, ON
  • Josée Pelletier, National Patient Advocacy Manager, Bristol Myers Squibb Canada, QC
  • Dr. Jennifer Rayner, Director of Research and Evaluation, Alliance for Healthier Communities, ON
  • Natalie Richardson, Managing Director, Save Your Skin Foundation, BC
  • Antonella Scali, Executive Director, Canadian Psoriasis Network, ON
  • Dr. Michael Smylie, Medical Oncologist, Cross Cancer Institute, Alberta Health Services, AB
  • Eva Villalba, Executive Director, Coalition Priorité Cancer au Québec, QC
  • Suzanne Wait, Managing Director, The Health Policy Partnership, London, UK

Secretariat:

  • Amy Rosvold, Project Manager, All.Can Canada
  • Leah Stephenson, Strategic Lead, All.Can Canada

As a member of All.Can, Save Your Skin Foundation is working in this area, adding Canadian perspective to the global project.  For more information please visit the All.Can website, and read more about the All.Can Canada initiative. To learn more about All.Can Canada or to inquire about getting involved, please email: all.can@saveyourskin.ca

together we can make a difference

Making awareness and education available is crucial. Since 2006, the Foundation has worked to raise awareness of melanoma and non-melanoma skin cancers focusing on education, prevention and the need for improved patient care.

Show Buttons
Hide Buttons